MedPath

Ultrasound Guided Anterior Quadratus Lumborum Block

Not Applicable
Completed
Conditions
Postoperative Pain
Ultrasound
Interventions
Procedure: Group P
Procedure: Group A
Registration Number
NCT03425162
Lead Sponsor
Bursa Yüksek İhtisas Education and Research Hospital
Brief Summary

Percutaneous nephrolithotomy (PNL) is frequently used today for renal stones. percutaneous nephrolithotomy (PNL) procedure has become the treatment of choice for many patients with symptomatic renal stones . Patients undergoing PNL suffer from acute postoperative pain, despite a multimodal analgesic regime.

This is a randomised controlled trial efficacy of the anterior Quadratus Lumborum Block (QLB) in terms of analgesic efficacy in patients who undergo percutaneous nephrolithotomy.

Detailed Description

Many analgesic procedures such as NSAID, opioid and regional anesthesia procedures are used as a part of multimodal analgesia for postoperative Percutaneous nephrolithotomy pain.

In this study we will use the ultrasound -guided anterior Quadratus Lumborum Block . Local anesthesic will be injected between quadratus lumborum muscle and psoas muscle with ultrasound.Analgesic effect of this block will be detected by using morphine consumption and visual analogue scale .

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients who were in the American Society of Anesthesiologists (ASA) I-III class and underwent elective Percutaneous nephrolithotomy
Exclusion Criteria
  • Previous history of opioid use preoperatively,

    • Allergy to local anesthetics,
    • The presence of any systemic infection,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group PGroup PGroup P:PCA (morphine)
Group AGroup AGroup A:Ultrasound guided unilateral anterior Quadratus Lumborum block with 20 ml %0.25 bupivacaine+PCA (morphine)
Group AMorphine SulfateGroup A:Ultrasound guided unilateral anterior Quadratus Lumborum block with 20 ml %0.25 bupivacaine+PCA (morphine)
Group PMorphine SulfateGroup P:PCA (morphine)
Primary Outcome Measures
NameTimeMethod
Visual Analog ScalePostoperative 24 hours

Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0= no pain, 10=intolerable pain)

Secondary Outcome Measures
NameTimeMethod
morphine consumptionPostoperative 24 hours

morphine consumption

additional analgesic usePostoperative 24 hours

additional analgesic use

side effect profilePostoperative 24 hours

side effect profile (Nausea and vomiting scale,Hypotension,Ramsay Sedation Scale)

1. Nausea and vomiting scale (nausea-vomiting scale (NVS): 1. No nausea is present, 2. Mild nausea is present. 3. Severe nausea is present. 4. Vomiting is present) In case of a NVS score of \>3, an anti-emetic drug was administered.

2. Hypotension

3. Ramsay Sedation Scale (Ramsay Sedation Scale (RSS) : 1. Anxiety, agitation are present; 2. Cooperated, awake; 3. Sedatized, response to commands; 4. Sleepy, immediately awoken by auditory stimulus or glabella tap; 5. Sleepy, deep response to auditory stimulus or glabella tap and 6. Sleepy, no response to auditory stimulus or glabella tap )

Trial Locations

Locations (1)

University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital

🇹🇷

Bursa, Turkey

© Copyright 2025. All Rights Reserved by MedPath